(19)
(11)
EP 1 620 464 A1
(12)
(43)
Date of publication:
01.02.2006
Bulletin 2006/05
(21)
Application number:
04730429.0
(22)
Date of filing:
30.04.2004
(51)
International Patent Classification (IPC):
C07K
14/595
(1995.01)
A61K
38/33
(1995.01)
C12N
15/09
(1990.01)
A61P
3/10
(2000.01)
C07K
14/50
(1995.01)
A61K
38/18
(1995.01)
A01K
67/027
(1990.01)
(86)
International application number:
PCT/CA2004/000648
(87)
International publication number:
WO 2004/096853
(
11.11.2004
Gazette 2004/46)
(84)
Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
(30)
Priority:
30.04.2003
US 509068 P
(71)
Applicant:
Waratah Pharmaceuticals, Inc.
Toronto, Ontario M5B 2E7 (CA)
(72)
Inventors:
BRAND, Stephen J,
Lincoln, MA 01773 (US)
CRUZ, Antonio
Toronto, Ontario M5P 2T7 (CA)
(74)
Representative:
Holliday, Louise Caroline
D Young & Co 120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)
(54)
COMBINED USE OF KERATINOCYTE GROWTH FACTOR AGONISTS AND GASTRIN COMPOUNDS